期刊文献+

补肾生血颗粒对慢性肾衰实验性大鼠血TNF和EPO的作用 被引量:1

Bushen Shengxue Particles Experimental Chronic Renal Failure on Blood TNF And The Role of EPO
下载PDF
导出
摘要 [目的]探讨补肾生血颗粒对慢性肾功能衰竭大鼠改善肾性贫血作用及血EPO、TNF的影响。[方法]采用腺嘌呤建立大鼠贫血模型,随机分为模型对照组、中药治疗组(补肾生血颗粒)、西药治疗组(促红素EPO)、中西药联合治疗组(补肾生血颗粒、EPO联用)。测血RBC、Hb、HCT、肾功、EPO及肿瘤坏死因子(TNF)的指标。[结果]与中药组及中西药联合应用组相比,补肾生血颗粒治疗肾性贫血的效果与EPO无明显差异(P>0.05),稍逊于中西药联合应用组(P<0.05),并能明显降低血BUN、Cr的含量(P<0.01),减轻肾组织病理损害,还可降低血TNF,提高血EPO的水平。[结论]补肾生血颗粒能有效治疗肾性贫血并能明显改善肾功能,提高血EPO含量,还有降低血TNF的作用。 [Objective] To investigate the blood particles Bushen chronic renal failure in rats to improve the role of renal anemia and blood EPO, TNF impact. [ Methods ] adenine anemia in rats were randomly divided into model control group, traditional Chinese medicine treatment group ( Bushen Shengxue particles) , western medicine treatment group ( EPO EPO) , in the treatment of western medicine group ( Bushen Shengxue particles, GC EPO). Measurement of blood RBC, Hb, HCT, renal function, EPO and tumor necrosis factor (TNF) indicators. [ Results ] and traditional Chinese medicine and western medicine group combined group, the treatment of kidney blood particle effect of renal anemia with EPO was no significant difference ( P > 0. 05 ) , less in the combination of western medicine group (P <0. 05) ,and can significantly lower blood BUN,Cr content (P <0. 01) ,reduce the pathological damage of renal tissue,can reduce the blood TNF,increase the blood level of EPO. [Conclusion]The blood particles Bushen effective treatment of renal anemia and renal function improved significantly improve the blood content of EPO,as well as to reduce the role of TNF in blood.
机构地区 铁岭市中医院
出处 《实用中医内科杂志》 2009年第9期33-34,共2页 Journal of Practical Traditional Chinese Internal Medicine
关键词 慢性肾衰 补肾生血颗粒 HB HCT 肾功 EPO TNF chronic renal failure Bushen Shengxue particles Hb HCT renal EPO TNF
  • 相关文献

参考文献4

二级参考文献40

  • 1刘海虹,徐立娟.补肾生血颗粒对慢性肾衰实验性大鼠血TNF和EPO的作用[J].实用中医内科杂志,2009,23(9):33-34. 被引量:1
  • 2刘海虹,何学红.补肾生血颗粒对实验性慢性肾衰大鼠血EP0及TNF的影响[J].辽宁中医药大学学报,2006,8(4):137-138. 被引量:4
  • 3任昊.肾性贫血[J].实用医学杂志,2007,23(5):768-769. 被引量:8
  • 4吕静,孙劲秋,何学红.补肾生血颗粒治疗慢性肾功能衰竭肾性贫血临床研究[J].实用中医内科杂志,2007,21(4):42-43. 被引量:7
  • 5Gimdt M, Kaul H, Leitnaker CK, et al. Selective sequestration of cytokineproducing monocytes during hemodialysis treatment. Am J Kidney Dis,2001.37(5).954 - 63.
  • 6Pecoits-Filho R, Barany P,Lindholm B,et al. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment . Nephrol Dial Transplant,2002,17(9), 1684 - 8.
  • 7Bologa RM, Levine DM,Parker TS,et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia , and mortality in hemodialysis patients. Am J Kidney Dis, 1998,32(1) ,107 - 14.
  • 8Irish A. Cantiovaseular disease,fibrinogen and the acute phase response: associations with lipids and blood pressure in patients with chronic renal disease. Atherosclerosis , 1998,137(1), 133 - 9.
  • 9Park CW,Shin YS, Kim CM,et al.Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients. Am J Kidney Dis,2002,40(6), 1230 - 9.
  • 10Torzewski J,Torzewsi M, Bowyer DE, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioccler Tromb Vasc Biol, 1998,18,1386 - 92.

共引文献141

同被引文献14

  • 1刘海虹,何学红.补肾生血颗粒对实验性慢性肾衰大鼠血EP0及TNF的影响[J].辽宁中医药大学学报,2006,8(4):137-138. 被引量:4
  • 2任昊.肾性贫血[J].实用医学杂志,2007,23(5):768-769. 被引量:8
  • 3吕静,孙劲秋,何学红.补肾生血颗粒治疗慢性肾功能衰竭肾性贫血临床研究[J].实用中医内科杂志,2007,21(4):42-43. 被引量:7
  • 4Kaysen GA.C-reactive protein:A story half told,2000(03).
  • 5Kato A;Odamaki M;TakitaT.High blood solube receptor P80for tumour necrosis factor-alpha is associated with erythro poietin resistance in HD patients[J],2001(09).
  • 6Drueke T.Hyporesponsiveness to recombinant human erythopoietin[J],2001(16).
  • 7Rao DS;Shih MS;Mohini R.Effect of serum parathyroid hormane and bone marrow fibrosis on the response to erythropoietin in uremia[J],1993.
  • 8Goicoechea M;Martin J;Sequera P.Role of cyrokines in the response to erythropoietin in HD patients[J],1998.
  • 9Gumnell J;Yeun JY;depner TA.A cute-phase response predicts erythropoitin resistance in HD and PD patients[J],1999(1).
  • 10Barany P;Divino JC;Bergstrom J.High C-Reactive Protein is a strong predictor of resistance to erythropoitin in HD patients,1997.

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部